// App-Quantinova.ai

ABS027 : SUBCUTANEOUS MARZEPTACOG ALFA (ACTIVATED) IS EFFECTIVE FOR ON‐DEMAND TREATMENT OF SPONTANEOUS BLEEDING IN HEMOPHILIA A RATS

Researchers

Presenter

  • T. Knudsen

Principal Investigators

  • P. B. Johansen

  • F. Del Greco

  • L. Neuman

  • H. Levy

  • J. Reckless

  • G. E. Blouse

Medical Centers

  • Crescendo Bioscience, South San Francisco, United States

  • RxCelerate, Cambridge, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

Disease

  • Hemophilia

  • Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

Biomarkers

  • N/A

Drug/Treatment

  • CB-813

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved